Resveratrol Protects Left Ventricle by Increasing Adenylate Kinase 1 and Isocitrate Dehydrogenase Activities in Rats with Myocardial Infarction

10.4077/CJP.2011.AMM097

Jeng-Feng Lin；Semon Wu；Shiang-Suo Huang；Bo-Yi Lu；Su-Man Lin；Shen-Kou Tsai

resveratrol ； adenylate kinase 1 ； isocitrate dehydrogenase ； myocardial infarction

The Chinese Journal of Physiology

54卷6期（2011 / 12 / 01）

406 - 412

英文

Our prior study had shown that resveratrol was a potent cardioprotective agent in rats with myocardial infarction (MI). In this study, we further evaluated the mechanism of cardioprotection of resveratrol by proteomic analysis. After permanent ligation of the left anterior descending artery under isoflurane anesthesia, surviving rats were randomly allocated to three groups and treated with resveratrol at 1 mg/kg/day (MI/R group), or vehicles (sham group and MI group) once daily for four weeks. In proteomic analysis, the MI group showed decreased expression of adenylate kinase 1 (AK1) and mitochondrial NADP(superscript +)-dependent isocitrate dehydrogenase (IDPm) after MI compared with the sham group. These variations were reversed by resveratrol in the MI/R group. Validation with Western blot and immunohistochemical analyses showed similar trends in protein expression profiling. Our studies suggest that the beneficial effects of resveratrol on ventricular modeling may be due to increased expression of AK1 and IDPm, which have been known to increase myocardial energetic efficiency and reduce reactive oxygen species-mediated damage, respectively.

1. Baur, J.A.,Pearson, K.J.,Price, N.L.,Jamieson, H.A.,Lerin, C.,Kalra, A.,Prabhu, V.V.,Allard, J.S.,Lopez-Lluch, G.,Lewis, K.,Pistell, P.J.,Poosala, S.,Becker, K.G.,Boss, O.,Gwinn, D.,Wang, M.,Ramaswamy, S.,Fishbein, K.W.,Spencer, R.G.,Lakatta, E.G.,Le Couteur, D.,Shaw, R.J.,Navas, P.,Puigserver, P.,Ingram, D.K.,de Cabo, R.,Sinclair, D.A.(2006).Resveratrol improves health and survival of mice on a high-calorie diet.Nature,444,337-342.
2. Braunwald, E.(2008).Biomarkers in heart failure.N. Engl. J. Med.,358,2148-2159.
3. Chen, C.J.,Yu, W.,Fu, Y.C.,Wang, X.,Li, J.L.,Wang, W.(2009).Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway.Biochem. Biophys. Res. Commun.,378,389-393.
4. Chen, Y.R.,Yi, F.F.,Li, X.Y.,Wang, C.Y.,Chen, L.,Yang, X.C.,Su, P.X.,Cai, J.R.(2008).Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction.Cardiovasc. Drugs Ther.,22,479-485.
5. Dargie, H.J.(2001).Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial.Lancet,357,1385-1390.
6. Dzeja, P.P.,Bast, P.,Pucar, D.,Wieringa, B.,Terzic, A.(2007).Defective metabolic signaling in adenylate kinase AK1 gene knockout hearts compromises post-ischemic coronary reflow.J. Biol. Chem.,282,31366-31372.
7. Dzeja, P.P.,Terzic, A.(2003).Phosphotransfer networks and cellular energetics.J. Exp. Biol.,206,2039-2047.
8. Dzeja, P.P.,Vitkevicius, K.T.,Redfield, M.M.,Burnett, J.C.,Terzic, A.(1999).Adenylate kinase catalyzed phosphotransfer in the myocardium: Increased contribution in heart failure.Circ. Res.,84,1137-1143.
9. Frankel, E.N.,Waterhouse, A.L.,Kinsella, J.E.(1993).Inhibition of human LDL oxidation by resveratrol.Lancet,341,1103-1104.
10. Fukuda, S.,Kaga, S.,Zhan, L.,Bagchi, D.,Das, D.K.,Bertelli, A.,Maulik, N.(2006).Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor flk-1.Cell. Biochem. Biophys.,44,43-49.
11. He, S.,Jiang, L.,Wu, B.,Pan, Y.,Sun, C.(2009).Pallidol, a resveratrol dimer from red wine, is a selective singlet oxygen quencher.Biochem. Biophys. Res. Commun.,379,283-287.
12. Hung, L.M.,Su, M.J.,Chen, J.K.(2004).Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.Free Radic. Biol. Med.,36,774-781.
13. Imamura, G.,Bertelli, A.A.,Bertelli, A.,Otani, H.,Maulik, N.,Das, D.K.(2002).Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice.Am. J. Physiol. Heart Circ. Physiol.,282,H1996-H2003.
14. Jo, S.H.,Son, M.K.,Koh, H.J.,Lee, S.M.,Song, I.H.,Kim, Y.O.,Lee, Y.S.,Jeong, K.S.,Kim, W.B.,Park, J.W.,Song, B.J.,Huh, T.L.(2001).Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase.J. Biol. Chem.,276,16168-16176.
15. Koshland, D.E.Jr.,Walsh, K.,LaPorte, D.C.(1985).Sensitivity of metabolic fluxes to covalent control.Curr. Top. Cell Regul.,27,13-22.
16. Lin, J.F.,Lin, S.M.,Chih, C.L.,Nien, M.W.,Su, H.H.,Hu, B.R.,Huang, S.S.,Tsai, S.K.(2008).Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.Life Sci.,83,313-317.
17. McGregor, E.,Dunn, M.J.(2006).Proteomics of the heart: unraveling disease.Circ. Res.,98,309-321.
18. Mizutani, K.,Ikeda, K.,Kawai, Y.,Yamori, Y.(2001).Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats.Clin. Exp. Pharmacol. Physiol.,28,55-59.
19. Pfeffer, M.A.,Braunwald, E.,Moye, L.A.,Basta, L.,Brown, E.J.Jr.,Cuddy, T.E.,Davis, B.R.,Geltman, E.M.,Goldman, S.,Flaker, G.C.(1992).Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.N. Engl. J. Med.,327,669-677.
20. Pfeffer, M.A.,Pfeffer, J.M.,Fishbein, M.C.,Fletcher, P.J.,Spadoro, J.,Kloner, R.A.,Braunwald, E.(1979).Myocardial infarct size and ventricular function in rats.Circ. Res.,44,503-512.
21. Pucar, D.,Bast, P.,Gumina, R.J.,Lim, L.,Drahl, C.,Juranic, N.,Macura, S.,Janssen, E.,Wieringa, B.,Terzic, A.,Dzeja, P.P.(2002).Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion.Am. J. Physiol. Heart Circ. Physiol.,283,H776-H782.
22. Richards, A.M.,Nicholls, M.G.,Espiner, E.A.,Lainchbury, J.G.,Troughton, R.W.,Elliott, J.,Frampton, C.,Turner, J.,Crozier, I.G.,Yandle, T.G.(2003).B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.Circulation,107,2786-2792.
23. Sawicki, G.,Leon, H.,Sawicka, J.,Sariahmetoglu, M.,Schulze, C.J.,Scott, P.G.,Szczesna-Cordary, D.,Schulz, R.(2005).Degradation of myosin light chain in isolated rat hearts subjected to ischemiareperfusion injury: a new intracellular target for matrix metalloproteinase- 2.Circulation,112,544-552.
24. Soleas, G.J.,Diamandis, E.P.,Goldberg, D.M.(1997).Wine as a biological fluid: history, production, and role in disease prevention.J. Clin. Lab. Anal.,11,287-313.
25. Velagaleti, R.S.,Pencina, M.J.,Murabito, J.M.,Wang, T.J.,Parikh, N.I.,D''Agostino, R.B.,Levy, D.,Kannel, W.B.,Vasan, R.S.(2008).Long-term trends in the incidence of heart failure after myocardial infarction.Circulation,118,2057-2062.
26. Xu, Q.,Hao, X.,Yang, Q.,Si, L.(2009).Resveratrol prevents hyperglycemia- induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase.Biochem. Biophys. Res. Commun.,388,389-394.
27. Ying, W.(2008).NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences.Antioxid. Redox. Signal,10,179-206.
28. Zeleznikar, R.J.,Heyman, R.A.,Graeff, R.M.,Walseth, T.F.,Dawis, S.M.,Butz, E.A.,Goldberg, N.D.(1990).Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle.J. Biol. Chem.,265,300-311.